CDKN2A and neoplasm: Patients with HOMDEL of CDKN2A exhibited lower levels of deep white matter invasion (47.1%), defined as “Enhancing or nCET tumor extending into the internal capsule, corpus callosum or brainstem” compared to those with HETLOSS or no alteration (75%) (p = 0.041).